Bolus Injection
Bolus Injection - Related Videos
00:59
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
0 Views •
2025
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration. Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM. We can also...
01:18
Two-Compartment Open Model: IV Bolus Administration
0 Views •
2025
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination. The disparity between drug input and the sum of drug transfer rates between...
01:19
One-Compartment Open Model for IV Bolus Administration: General Considerations
0 Views •
2025
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body. The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
03:20
Intrarenal Injection of E. coli into the Renal Pelvis of a Rat
0 Views •
2026
Source: Gupta, K., et al. Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis. J. Vis. Exp. (2017).This video demonstrates the intrarenal injection of E. coli into the renal pelvis of an anesthetized rat to induce a localized kidney infection, modeling acute pyelonephritis. It highlights key surgical steps and aseptic techniques necessary for establishing a reproducible in vivo infection model for downstream analysis.
00:56
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
0 Views •
2025
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications. In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
FAQs
An intravenous bolus produces especially rapid systemic exposure because the drug enters the bloodstream over a short period. Its plasma concentration therefore rises promptly, and the resulting concentration–time profile reflects the administered dose and the speed of delivery. This rapid rise explains why intravenous administration can be useful when treatment requires an immediate therapeutic response.
The observed plasma concentration after a bolus depends on more than the nominal dose. Route of administration, absorption, and bioavailability influence how much drug reaches systemic circulation and how quickly it appears there. Consequently, the same medication amount can produce different concentration patterns when delivered by different routes.
Bolus kinetics connects dosing decisions with concentration–time profiles. A rapid dose creates a prominent early concentration rise, so interpretation should consider both the initial peak and the later profile. This framework allows clinicians and pharmacology researchers to relate expected plasma concentrations to therapeutic goals and recognize why peak-related effects require attention.
Bolus Injection may be selected as a loading dose when clinicians need to establish therapeutic exposure promptly, or during acute treatment when a rapid effect is important. It can also provide medication to supplement an infusion. These uses make the approach relevant to urgent pharmacologic management and to treatment that is already being supplied by infusion.
When an infusion is delivering medication but additional supplementation is needed, a bolus provides a separate, defined dose over a short period. The choice of timing and dose requires attention to the desired therapeutic benefit and the possibility of peak-related adverse effects. Supplementation therefore changes the exposure pattern rather than merely increasing the amount delivered by infusion.
A concentration–time profile shows how plasma exposure develops after administration, including the prompt rise associated with a short delivery period and the influence of route, dose, absorption, and bioavailability. In pharmacology, interpreting this profile helps connect an administration decision with its expected therapeutic effect and with adverse effects associated with high concentrations.